LicianPro

SYRE holders · STATE STREET CORP 13F · SYRE stock

STATE STREET CORP Spyre Therapeutics Inc. (SYRE) 13F holding

STATE STREET CORP reported 3,057,416 SYRE shares valued at $271.4M as of 2026-06-30. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.

Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.